The Clinical Impact of Critical Microbiology Results
Title: The Clinical Impact of Critical Microbiology Results
Date: Tuesday, April 23, 2019
Time: 3 p.m. ET
Presenter: James A. McKinnell, MD
Unless otherwise noted, P.A.C.E.™ accreditation will expire six months after the live webinar.
Challenging Bacterial Infections
Accurate antimicrobial susceptibility results are never more important than when addressing serious bacterial infections like carbapenem-resistant Enterobacteriaceae, Pseudomonas, and Acinetobacter. When treating patients, clinicians rely on these results from the microbiology laboratory to help guide their decisions.
In this P.A.C.E.-accredited Fisher Healthcare webinar, James A. McKinnell, MD, will discuss how microbiologists can help steer antibiotic treatment choices that are critical to patient care, including reliable detection of existing and emerging resistance to new drugs and antimicrobials of last resort. You’ll gain insight into results from microbiology laboratories that can potentially impact patient care.
This webinar will help you:
- Evaluate a challenging case from both clinical and laboratory perspectives
- Compare testing options for rapid identification of resistant infections
- Explain the changing epidemiology of Candida infections
- Recognize the need for ongoing breakpoint updates
This webinar is produced by Whitehat Communications, a provider of continuing education programs in clinical laboratory sciences that has been approved by the ASCLS P.A.C.E. Program. One P.A.C.E. credit hour will be provided for this complimentary, basic-level program.
James A. McKinnell, MD
Dr. McKinnell is an Assistant Professor of Medicine at the David Geffen School of Medicine at the University of California, Los Angeles. He is also a member of the Infectious Disease Clinical Outcome Research Unit (ID-CORE) and the Los Angeles Biomedical Research Institute at Harbor-UCLA.
As a nationally recognized infectious disease specialist, McKinnell’s interests relate to the clinical management and prevention of healthcare-associated infections. He has published more than 40 papers, many of which promote the optimal use of antibiotics and antimicrobial resistance within the community.